The use of dupilumab in treatment-refractory eosinophilic fasciitis.

Ann Allergy Asthma Immunol

Human Eosinophil Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11334165PMC
http://dx.doi.org/10.1016/j.anai.2024.05.015DOI Listing

Publication Analysis

Top Keywords

dupilumab treatment-refractory
4
treatment-refractory eosinophilic
4
eosinophilic fasciitis
4
dupilumab
1
eosinophilic
1
fasciitis
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!